Drobne D - Search Results

1

Success and safety of high infliximab trough levels in inflammatory bowel disease.

Drobne D, Kurent T, Golob S, Svegl P, Rajar P, Terzic S, Kozelj M, Novak G, Smrekar N, Plut S, Sever N, Strnisa L, Hanzel J, Brecelj J, Urlep D, Osredkar J, Homan M, Orel R, Stabuc B, Ferkolj I, Smid A. Drobne D, et al. Scand J Gastroenterol. 2018 Aug;53(8):940-946. doi: 10.1080/00365521.2018.1486882. Epub 2018 Jul 10. Scand J Gastroenterol. 2018. PMID: 29987967

2

Acute biliary pancreatitis: detection of common bile duct stones with endoscopic ultrasound.

Stabuc B, Drobne D, Ferkolj I, Gruden A, Jereb J, Kolar G, Mlinaric V, Mervic M, Repse A, Stepec S, Markovic S. Stabuc B, et al. Among authors: drobne d. Eur J Gastroenterol Hepatol. 2008 Dec;20(12):1171-5. doi: 10.1097/MEG.0b013e32830a9a31. Eur J Gastroenterol Hepatol. 2008. PMID: 18989141

3

Early trough levels and antibodies to infliximab predict safety and success of reinitiation of infliximab therapy.

Baert F, Drobne D, Gils A, Vande Casteele N, Hauenstein S, Singh S, Lockton S, Rutgeerts P, Vermeire S. Baert F, et al. Among authors: drobne d. Clin Gastroenterol Hepatol. 2014 Sep;12(9):1474-81.e2; quiz e91. doi: 10.1016/j.cgh.2014.01.033. Epub 2014 Jan 29. Clin Gastroenterol Hepatol. 2014. PMID: 24486408

4

Withdrawal of immunomodulators after co-treatment does not reduce trough level of infliximab in patients with Crohn's disease.

Drobne D, Bossuyt P, Breynaert C, Cattaert T, Vande Casteele N, Compernolle G, Jürgens M, Ferrante M, Ballet V, Wollants WJ, Cleynen I, Van Steen K, Gils A, Rutgeerts P, Vermeire S, Van Assche G. Drobne D, et al. Clin Gastroenterol Hepatol. 2015 Mar;13(3):514-521.e4. doi: 10.1016/j.cgh.2014.07.027. Epub 2014 Jul 25. Clin Gastroenterol Hepatol. 2015. PMID: 25066841

5

Down-regulation of microRNAs of the miR-200 family and up-regulation of Snail and Slug in inflammatory bowel diseases - hallmark of epithelial-mesenchymal transition.

Zidar N, Boštjančič E, Jerala M, Kojc N, Drobne D, Štabuc B, Glavač D. Zidar N, et al. Among authors: drobne d. J Cell Mol Med. 2016 Oct;20(10):1813-20. doi: 10.1111/jcmm.12869. Epub 2016 Apr 26. J Cell Mol Med. 2016. PMID: 27113480 Free PMC article.

6

Clinically important neutralizing anti-drug antibodies detected with an in-house competitive ELISA.

Ogrič M, Žigon P, Lakota K, Praprotnik S, Drobne D, Štabuc B, Sodin-Semrl S, Čučnik S. Ogrič M, et al. Among authors: drobne d. Clin Rheumatol. 2019 Feb;38(2):361-370. doi: 10.1007/s10067-018-4213-0. Epub 2018 Jul 16. Clin Rheumatol. 2019. PMID: 30014359

7

Dendritic cell profiles in the inflamed colonic mucosa predict the responses to tumor necrosis factor alpha inhibitors in inflammatory bowel disease.

Smrekar N, Drobne D, Smid LM, Ferkolj I, Stabuc B, Ihan A, Kopitar AN. Smrekar N, et al. Among authors: drobne d. Radiol Oncol. 2018 Nov 26;52(4):443-452. doi: 10.2478/raon-2018-0045. Radiol Oncol. 2018. PMID: 30511938 Free PMC article.

8

Routinely utilized in-house assays for infliximab, adalimumab and their anti-drug antibody levels.

Ogrič M, Žigon P, Drobne D, Štabuc B, Sodin-Semrl S, Čučnik S, Praprotnik S. Ogrič M, et al. Among authors: drobne d. Immunol Res. 2018 Dec;66(6):726-736. doi: 10.1007/s12026-018-9050-3. Immunol Res. 2018. PMID: 30569379

9

Optimised infliximab monotherapy is as effective as optimised combination therapy, but is associated with higher drug consumption in inflammatory bowel disease.

Drobne D, Kurent T, Golob S, Švegl P, Rajar P, Hanžel J, Koželj M, Novak G, Smrekar N, Ferkolj I, Štabuc B. Drobne D, et al. Aliment Pharmacol Ther. 2019 Apr;49(7):880-889. doi: 10.1111/apt.15179. Epub 2019 Feb 19. Aliment Pharmacol Ther. 2019. PMID: 30784100

10

Early vedolizumab trough levels predict combined endoscopic and clinical remission in inflammatory bowel disease.

Hanžel J, Sever N, Ferkolj I, Štabuc B, Smrekar N, Kurent T, Koželj M, Novak G, Compernolle G, Tops S, Gils A, Drobne D. Hanžel J, et al. Among authors: drobne d. United European Gastroenterol J. 2019 Jul;7(6):741-749. doi: 10.1177/2050640619840211. Epub 2019 Mar 19. United European Gastroenterol J. 2019. PMID: 31316778 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

213 results

Search Page

Filters